Abiomed acquires ECP

The acquisition of ECP by Abiomed will strengthen its IP portfolio of cardiac technologies

On July 1, Abiomed, Inc. announced its acquisition of Berlin-based medical device company ECP Entwicklungsgesellschaft mbH (ECP). ECP is in the process of developing a percutaneous catheter pump designed to increase blood circulation up to a flow rate of 4.5 liters a minute through an external drive shaft.

Already a leading provider of heart support technologies, Abiomed will strengthen its position with intellectual property focused on axial and expandable pump capabilities. With the acquisition of ECP, the company will continue to work on providing technologies and strategies for minimally invasive procedures during complex hemodynamic and percutaneous treatment.

Contributing Author

author image

Jessica Liu

Jessica Liu is a sophomore at Haverford College, where she is majoring in political science. At InsideCounsel, she reports on news for the Women, Influence,...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.